ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
66 hedge funds and large institutions have $155M invested in ChemoCentryx, Inc. in 2014 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 29 reducing their positions, and 10 closing their positions.
19% more call options, than puts
Call options by funds: $347K | Put options by funds: $291K
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
2% more funds holding
Funds holding: 65 → 66 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less capital invested
Capital invested by funds: $176M → $155M (-$21.2M)
55% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 29
Top Buyers
Top Sellers
CCXI Hedge Fund Activity: Q2 2014 in Review
66 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q2 2014, worth a combined $155M — down 12% from $176M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CCXI positions and 10 closed out — a net gain of 1 holder — while 13 added to existing stakes and 29 trimmed.
The largest buyer was Balyasny Asset Management, adding an estimated $2.6M. The largest seller was Great Point Partners, exiting entirely with an estimated $1.66M sold.
- 66 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q2 2014, up from 65 in Q1 2014.
- Funds reported $155M of ChemoCentryx, Inc. stock for Q2 2014, down 12% quarter-over-quarter.
- 11 funds opened new ChemoCentryx, Inc. positions in Q2 2014 and 10 closed out, a net change of +1 holder.
- The largest ChemoCentryx, Inc. buyer in Q2 2014 was Balyasny Asset Management, an estimated $2.6M added.
- The largest ChemoCentryx, Inc. seller in Q2 2014 was Great Point Partners, an estimated $1.66M sold.
Based on aggregated 13F filings for Q2 2014.